Leadership and Administration Core

领导和行政核心

基本信息

项目摘要

The goal of the Leadership and Administration Core is to ensure that translational goals of the POCRC are met and that resources are used effectively. The Leadership Core is responsible for ongoing evaluation of scientific and translational progress of all projects. If progress is not sufficient, the Executive Committee comprised of Dr. Nicole Urban, Principal Investigator, and co-principal investigators, Drs. Mary (Nora) Disis, Charles Drescher, Beth Karlan, Steve Collins, and Martin (Mac) Cheever, will take necessary action. The Executive Committee is also responsible for ensuring that cores meet the needs of projects without redundancy or confiict, providing scientific leadership, facilitafing Inter-SPORE communication, coordinafing collaborations, integrating POCRC and CCSG activities, and allocating SPORE resources. The,Leadership Core will be responsible for coordinating SPORE activities and assuring communication between the cores, projects and committees. Committees within the Leadership Core will include representation from members ofthe Patient Advocate Group to make certain that the POCRC constanfiy works towards achieving its translational goals and meeting the needs ofthe patient. The Leadership Core will provide overall guidance for the translational activities ofthe SPORE, building on established interdisciplinary collaborations. It will promote, oversee, and evaluate active interaction between the cores and the projects. Through the advisory boards and committees, the Leadership Core will provide the following functions: 1) overall management and coordination ofthe SPORE; 2) meet the scientific advisory needs of the individual research projects; 3) oversee, plan, and evaluate SPORE acfivifies including inter¿ SPORE activities; 4) promote, oversee, and evaluate interaction of cores and projects; 5) encourage, select, and guide developmental projects; 6) provide mentoring and career development; 7) manage, distribute, and re-allocate SPORE funds and other resources as appropriate; 8) oversee IRB activity; 9) ensure that scientific objectives can ultimately be translated to patient care; 10) initiate new activities in response to important translational research opportunities. To address the needs of the projects and the cores, experts in ovarian cancer, translational research, early detection/screening, epidemiology, genomics, immunology, statistical methods, informatics, and pathology have been identified and recruited to serve in the Leadership Core. Senior leaders with relevant expertise will interact with each other on substantive committees as well as provide mentorship to POCRC investigators who are experts in their own fields but less acquainted with other disciplines that are critical to career development in ovarian cancer translational research and the overall success ofthe POCR(Z;. RELEVANCE (See instructions): The goal of this ovarian SPORE is to demonstrate better strategies for 1) screening high-risk women using novel serum markers and state-of-the-art imaging without the need for another large trial, by integrating our Phase I trial results with reports from ongoing Phase III efficacy trials; 2) selecting women for neoadjuvant therapy by testing their blood for a resectability signature; and 3) immunizing women against their own tumors to prevent recurrence. Success in one or more of these efforts will significantly reduce the burden of ovarian cancer.
领导力和管理核心的目标是确保POCRC的翻译目标是 满足并有效地使用了资源。领导力核心负责持续评估 所有项目的科学和翻译进展。如果进步还不够,执行委员会 首席调查员兼联合主持调查员Nicole Urban博士完成。玛丽(诺拉)迪斯, 查尔斯·德雷舍(Charles Drescher),贝丝·卡兰(Beth Karlan),史蒂夫·柯林斯(Steve Collins)和马丁(Mac)Cheever将采取必要的行动。这 执行委员会还负责确保核心满足没有项目需求 冗余或冲突,提供科学领导力,促进跨越跨越沟通,坐标 合作,集成POCRC和CCSG活动以及分配孢子资源。 领导力核心将负责协调孢子活动并确保交流 在核心,项目和委员会之间。领导力核心内的委员会将包括 患者倡导者小组成员的代表性确保POCRC CONSTANFIY 致力于实现其翻译目标并满足患者的需求。领导力核心 将为既定的孢子的翻译活动提供总体指导 跨学科合作。它将促进,监督和评估核心之间的主动相互作用 和项目。通过咨询委员会和委员会,领导核心将提供 以下功能:1)孢子的总体管理和协调; 2)符合科学咨询 各个研究项目的需求; 3)监督,计划和评估包括Inter的孢子学分 孢子活动; 4)促进,监督和评估核心与项目的相互作用; 5)鼓励,选择, 并指导发展项目; 6)提供心理和职业发展; 7)管理,分发和 重新分配孢子资金和其他资源; 8)监督IRB活动; 9)确保这一点 科学目标最终可以转化为患者护理; 10)启动新活动以回应 重要的翻译研究机会。 为了满足项目和核心的需求,卵巢癌专家翻译研究,早期 检测/筛查,流行病学,基因组学,免疫学,统计方法,信息和病理学 已被确定并招募以在领导核心中服务。相关专家的高级领导者 将在实体委员会上相互互动,并为POCRC提供精明权 研究人员是自己领域的专家 卵巢癌转化研究的职业发展和POCR的整体成功(Z;。 相关性(请参阅说明): 该卵巢孢子的目的是为1)筛查高风险妇女使用更好的策略 通过整合我们 I期试验结果以及正在进行的III期有效试验的报告; 2)为新辅助选择女性 通过测试血液的可切除性特征来治疗; 3)妇女免疫自己 防止复发的肿瘤。在其中一项或多项努力中的成功将大大减少燃烧 卵巢癌。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nicole Denise Urban其他文献

Nicole Denise Urban的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nicole Denise Urban', 18)}}的其他基金

Validation of a risk assessment decision rule for epithelial ovarian cancer
上皮性卵巢癌风险评估决策规则的验证
  • 批准号:
    8571907
  • 财政年份:
    2013
  • 资助金额:
    $ 8.07万
  • 项目类别:
Validation of a risk assessment decision rule for epithelial ovarian cancer
上皮性卵巢癌风险评估决策规则的验证
  • 批准号:
    8735102
  • 财政年份:
    2013
  • 资助金额:
    $ 8.07万
  • 项目类别:
Prevention of Ovarian Cancer in Women Participating in Mammography
参加乳房X光检查的女性预防卵巢癌
  • 批准号:
    7406542
  • 财政年份:
    2007
  • 资助金额:
    $ 8.07万
  • 项目类别:
Prevention of Ovarian Cancer in Women Participating in Mammography
参加乳房X光检查的女性预防卵巢癌
  • 批准号:
    7497462
  • 财政年份:
    2007
  • 资助金额:
    $ 8.07万
  • 项目类别:
Prevention of Ovarian Cancer in Women Participating in Mammography
参加乳房X光检查的女性预防卵巢癌
  • 批准号:
    7680268
  • 财政年份:
    2007
  • 资助金额:
    $ 8.07万
  • 项目类别:
Core--Leadership
核心——领导力
  • 批准号:
    6989597
  • 财政年份:
    2004
  • 资助金额:
    $ 8.07万
  • 项目类别:
Modeling ovarian cancer screening for CEA
CEA 卵巢癌筛查建模
  • 批准号:
    6522029
  • 财政年份:
    2002
  • 资助金额:
    $ 8.07万
  • 项目类别:
Modeling ovarian cancer screening for CEA
CEA 卵巢癌筛查建模
  • 批准号:
    6948847
  • 财政年份:
    2002
  • 资助金额:
    $ 8.07万
  • 项目类别:
Modeling ovarian cancer screening for CEA
CEA 卵巢癌筛查建模
  • 批准号:
    6765872
  • 财政年份:
    2002
  • 资助金额:
    $ 8.07万
  • 项目类别:
Modeling ovarian cancer screening for CEA
CEA 卵巢癌筛查建模
  • 批准号:
    6606207
  • 财政年份:
    2002
  • 资助金额:
    $ 8.07万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

SCIP, HOP & JUMP: Summer Clinical Immersion Program, Hands on Prototyping, and Jump-starting Design Projects towards Translation
SCIP、HOP
  • 批准号:
    10685931
  • 财政年份:
    2019
  • 资助金额:
    $ 8.07万
  • 项目类别:
The role of ENDS use in changing rates of escalation and quitting of cigarette smoking in those under age 35 years in US population
ENDS 使用对改变美国 35 岁以下人群吸烟升级和戒烟率的作用
  • 批准号:
    10011784
  • 财政年份:
    2018
  • 资助金额:
    $ 8.07万
  • 项目类别:
Identifying Children and Teens at Risk for Early Onset Alcohol Use: An Innovative Application of Machine Learning Algorithms to Prevention
识别有早期饮酒风险的儿童和青少年:机器学习算法在预防中的创新应用
  • 批准号:
    9753696
  • 财政年份:
    2018
  • 资助金额:
    $ 8.07万
  • 项目类别:
Recruitment and Assessment Core
招聘与考核核心
  • 批准号:
    10227715
  • 财政年份:
    2017
  • 资助金额:
    $ 8.07万
  • 项目类别:
Efficacy of Couples-Based HIV Prevention in Vulnerable Young Men
基于夫妇的艾滋病毒预防对弱势年轻男性的功效
  • 批准号:
    9355070
  • 财政年份:
    2016
  • 资助金额:
    $ 8.07万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了